Education
About Us
Working with TipRanks
Follow Us
Biora Therapeutics (BIORQ)
OTHER OTC:BIORQ
BIORQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.08 - $7.90
Previous CloseN/A
Volume23.93K
Average Volume (3M)11.50K
Market Cap
$738.11K
Enterprise ValueN/A
Total Cash (Recent Filing)$3.20M
Total Debt (Recent Filing)$39.65M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Aug 18, 2025EPS Estimate
-3.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.03
Shares Outstanding4,522,702
10 Day Avg. Volume10,271
30 Day Avg. Volume11,497
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$23.00Price Target Upside14275.00% Upside
Rating ConsensusHold
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Clinical TrialsPositive results from the BT-600 Phase 1 clinical trial were presented at a major gastroenterology conference, highlighting potential advances in treatment.
Product DevelopmentThe new smaller BioJet device increases payload capacity and ease of administration, potentially expanding its applications and market interest.
Product Safety And EfficacyThe NaviCap device is developing as a safe and effective means to deliver medication directly to the colon, with minimal systemic exposure.
Strategic AlignmentBiora's strategic realignment to focus on the BioJet program aims to expedite results crucial for licensing and partnering discussions with major pharmaceutical companies.
Bears Say
Financial PerformanceBiora reported a third-quarter EPS of ($5.04), missing both the estimate of ($4.20) and the consensus estimate of ($3.85).
Ownership Overview
Currently, No data available
---
BIORQ FAQ
What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $0.08 and its highest was $7.90 in the past 12 months.
What is Biora Therapeutics’s market cap?
Biora Therapeutics’s market cap is $738.11K.
When is Biora Therapeutics’s upcoming earnings report date?
Biora Therapeutics’s upcoming earnings report date is Aug 18, 2025 which is in 60 days.
How were Biora Therapeutics’s earnings last quarter?
Currently, no data Available
Is Biora Therapeutics overvalued?
According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued.
Does Biora Therapeutics pay dividends?
Biora Therapeutics does not currently pay dividends.
What is Biora Therapeutics’s EPS estimate?
Biora Therapeutics’s EPS estimate is -3.5.
How many shares outstanding does Biora Therapeutics have?
Biora Therapeutics has 4,522,702 shares outstanding.
What happened to Biora Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biora Therapeutics?
Currently, no hedge funds are holding shares in BIORQ
Company Description
Biora Therapeutics
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
Technical Analysis
Salarius Pharmaceuticals
―
Entero Therapeutics
―
Processa Pharmaceuticals
―
GRI Bio
―
ZyVersa Therapeutics
―